16472937

Source:http://linkedlifedata.com/resource/pubmed/id/16472937

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017296, umls-concept:C0205195, umls-concept:C0279025, umls-concept:C0301872, umls-concept:C0376358, umls-concept:C0443252, umls-concept:C0444498, umls-concept:C1516213, umls-concept:C1522449
pubmed:issue	1
pubmed:dateCreated	2006-4-18
pubmed:abstractText	To explore long-term immune responses after combined radio-gene-hormonal therapy.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/P50-58204
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16472937-17126227
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Acyclovir, http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Thymidine Kinase, http://linkedlifedata.com/resource/pubmed/chemical/Valine, http://linkedlifedata.com/resource/pubmed/chemical/valacyclovir
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0360-3016
pubmed:author	pubmed-author:Aguilar-CordovaEstuardoE, pubmed-author:ButlerE BrianEB, pubmed-author:FattahElmoataz AbdelEA, pubmed-author:FujitaTetsuoT, pubmed-author:KusakaNobuyukiN, pubmed-author:MaiWei-YuanWY, pubmed-author:NaruishiKojiK, pubmed-author:SatohTakefumiT, pubmed-author:TehBin SBS, pubmed-author:ThompsonTimothy CTC, pubmed-author:TimmeTerry LTL
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	65
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	84-90
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:16472937-Acyclovir, pubmed-meshheading:16472937-Adenoviridae, pubmed-meshheading:16472937-Aged, pubmed-meshheading:16472937-Aged, 80 and over, pubmed-meshheading:16472937-Androgen Antagonists, pubmed-meshheading:16472937-Antiviral Agents, pubmed-meshheading:16472937-CD4-Positive T-Lymphocytes, pubmed-meshheading:16472937-CD8-Positive T-Lymphocytes, pubmed-meshheading:16472937-Combined Modality Therapy, pubmed-meshheading:16472937-Gene Therapy, pubmed-meshheading:16472937-Humans, pubmed-meshheading:16472937-Immunity, Cellular, pubmed-meshheading:16472937-Killer Cells, Natural, pubmed-meshheading:16472937-Male, pubmed-meshheading:16472937-Middle Aged, pubmed-meshheading:16472937-Prostatic Neoplasms, pubmed-meshheading:16472937-Radiotherapy, Intensity-Modulated, pubmed-meshheading:16472937-Thymidine Kinase, pubmed-meshheading:16472937-Valine
pubmed:year	2006
pubmed:articleTitle	Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients.
pubmed:affiliation	Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II, Clinical Trial, Phase I, Research Support, N.I.H., Extramural